Literature DB >> 15983946

Emergent technologies for 3-dimensional image-guided radiation delivery.

David A Jaffray1.   

Abstract

Radiation therapy targeting is being refined to formally accommodate location of gross disease, microscopic extension, and geometric uncertainties in the delivery process. This formalization allows the disciplines in radiation oncology practice to work collaboratively to assure target coverage while attempting to minimize toxicity in adjacent normal structures. There is a growing expectation that the precise and accurate placement of radiation dose is well in hand. The development of volumetric imaging systems integrated with the medical linear accelerator for the specific purpose of guiding therapy will permit localization and targeting of soft-tissue structures at the time of treatment. In this review, the context for development of image-guided radiation therapy is discussed, and the growing expectation of volumetric guidance is portrayed through the various technologies currently being explored in the radiation therapy community.

Entities:  

Mesh:

Year:  2005        PMID: 15983946     DOI: 10.1016/j.semradonc.2005.01.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  25 in total

1.  Evaluations of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer.

Authors:  Han Liu; Qiuwen Wu
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Randomized controlled trials in health technology assessment: overkill or overdue?

Authors:  Søren M Bentzen
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

3.  Region-of-interest image reconstruction with intensity weighting in circular cone-beam CT for image-guided radiation therapy.

Authors:  Seungryong Cho; Erik Pearson; Charles A Pelizzari; Xiaochuan Pan
Journal:  Med Phys       Date:  2009-04       Impact factor: 4.071

Review 4.  Multimodality image registration with software: state-of-the-art.

Authors:  Piotr J Slomka; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

5.  RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies.

Authors:  Dian Wang; Walter Bosch; David Roberge; Steven E Finkelstein; Ivy Petersen; Michael Haddock; Yen-Lin E Chen; Naoyuki G Saito; David G Kirsch; Ying J Hitchcock; Aaron H Wolfson; Thomas F DeLaney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-15       Impact factor: 7.038

6.  A BPF-FBP tandem algorithm for image reconstruction in reverse helical cone-beam CT.

Authors:  Seungryong Cho; Dan Xia; Charles A Pellizzari; Xiaochuan Pan
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

Review 7.  MR-guided radiation therapy: transformative technology and its role in the central nervous system.

Authors:  Yue Cao; Chia-Lin Tseng; James M Balter; Feifei Teng; Hemant A Parmar; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 8.  Current status of IMRT in head and neck cancer.

Authors:  Jaime Gomez-Millan; Jesús Romero Fernández; Jose Antonio Medina Carmona
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-20

9.  Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results.

Authors:  X Allen Li; Xiaojian Chen; Qiang Zhang; David G Kirsch; Ivy Petersen; Thomas F DeLaney; Carolyn R Freeman; Andy Trotti; Ying Hitchcock; Meena Bedi; Michael Haddock; Kilian Salerno; George Dundas; Dian Wang
Journal:  Pract Radiat Oncol       Date:  2015-11-17

10.  Retroperitoneal tumour radiotherapy: clinical improvements using kilovoltage cone beam computed tomography.

Authors:  Xavier J Juan-Senabre; Carlos Ferrer-Albiach; Marta Rodríguez-Cordón; Agustín Santos-Serra; Juan López-Tarjuelo; Salvador Calzada-Feliu
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.